European Association of Urology has selected Dicot's study result to be presented
Press release: Uppsala, December 21, 2021. The pharmaceutical company Dicot announces that the results showing effect of Dicot's drug candidate in a disease animal model will be presented at the European Association of Urology's (EAU) annual congress 2022 in Amsterdam.The European Association of Urology (EAU) has announced that study results from Dicot's drug candidate will be presented at the EAU's annual congress in Amsterdam in March 2022. Thousands of abstracts from scientists are submitted to EAU. EAU annual congress is the central platform for successful research and innovation.